Progenics Pharmaceuticals, Inc. announced the election of Bradley Campbell to the company's Board of Directors. Mr. Campbell brings to the company's extensive experience in the biopharmaceutical industry, with particular expertise in the areas of corporate strategy, commercial operations and planning, business development and sales and marketing. He currently serves as President and Chief Operating Officer of Amicus Therapeutics.